Search clinical trials for: IO-108 tislelizumab

Total 5120 results

Immune-Onc Therapeutics

Completed

Dose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid Tumors

Advanced Solid Tumor

China
Immune-Onc Therapeutics
Regeneron Pharmaceuticals

Completed

First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid Tumors

Solid Tumor, Adult

United States
PhotonMD, Inc

Completed

Modulated Light Therapy in Participants With Pattern Hair Loss

Androgenetic Alopecia

Australia
WellSpan Health
University of Pennsylvania

Completed

Intraosseous Access in the Emergency Department for Patients With Failed Attempts at Intravenous Access: A Randomized Trial Examining Resource Utilization and Patient Satisfaction

Difficult Peripheral IV Access

United States
Second Affiliated Hospital, School of Medicine,...
The First Affiliated Hospital with Nanjing Medical University; Shanghai Zhongshan... and other collaborators

Recruiting

Intraosseous Versus Intravenous Vascular Access During Resuscitation Following Out-of-Hospital Cardiac Arrest

Out-of-Hospital Cardiac Arrest

China
Sultan Qaboos University
Christian Medical College, Vellore, India

Unknown

Symmetrical Versus Asymmetrical Surgery for Asymmetrical Inferior Oblique Overaction

Strabismus

Oman
Implandata Ophthalmic Products GmbH

Completed

Long-term Safety and Performance of the ARGOS-IO Intraocular Pressure Sensor System in Subjects With Primary Open Angle Glaucoma (POAG)

Primary Open-angle Glaucoma

Germany
Implandata Ophthalmic Products GmbH

Completed

Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation

Congenital Glaucoma | Stevens-Johnson Syndrome | Graft vs Host Disease | Congenital Aniridia | Chemical Burns

Germany
Sun Yat-sen University

Recruiting

Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery

Immunotherapy | DMMR Colorectal Cancer | Anti PD-1

China
Vidacare Corporation

Completed

Observation of Intraosseous Vascular Access in the Emergency Department

Patients Requiring Urgent Vascular Access

United States
Vidacare Corporation

Completed

Continuous Intraosseous Vascular Access Over 48 Hours

Intraosseous Vascular Access

United States
Immune-Onc Therapeutics
California Institute for Regenerative Medicine (CIRM)

Recruiting

IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML

CMML | AML With Monocytic Differentiation

United States
PulseMedica

Completed

Real-time Eye Tracking and Imaging of the Eye in Diabetic Retinopathy Patients

Diabetic Retinopathy | Retinal Imaging

Canada
Implandata Ophthalmic Products GmbH

Completed

Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG)

Primary Open Angle Glaucoma (POAG)

Germany
University of Oxford

Completed

A BCG Challenge Model Study to Assess Anti-mycobacterial Immunity Induced by BCG and a Candidate TB Vaccine, MVA85A

Tuberculosis

United Kingdom
Seoul National University Hospital
Seoul National University Bundang Hospital; SMG-SNU Boramae Medical Center; Ewha...

Unknown

VolumE maNagement Under Body Composition Monitoring in Critically Ill patientS on CRRT

Fluid Overload | Renal Dialysis

Korea, Republic of
Vidacare Corporation

Completed

Follow-Up Study Validating a Blended Technique

Intraosseous Vascular Access

United States
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung Cancer

Lung Cancer
Rutgers, The State University of New Jersey

Completed

Intraosseous Catheter Confirmation Study

Critical Illness

United States
Binx Health Limited

Completed

Evaluation of the Atlas Genetics io® CTNG System (IO-CTNG)

Gonorrhea | Chlamydia Trachomatis

United States
Baxano Surgical, Inc.

Unknown

The iO-Flex® Study: Evaluation of the Baxano iO-Flex® System for Decompressive Lumbar Surgery

Lumbar Spinal Stenosis

United States
Wake Forest University Health Sciences

Completed

Intraosseous Versus Intravenous Vascular Access During Cardiac Arrest

Cardiac Arrest

United States
Vidacare Corporation

Completed

Healthy Adult Volunteer Study of Intraosseous Infusion Using the Sternum

Intraosseous Vascular Access

United States
Lazarski University
Poznan University of Medical Sciences; Wroclaw Medical University; Medical University...

Completed

Intravascular Access of COVID-19 Patient Under Personal Protective Equipment

Emergencies | Cardiac Arrest

Poland
Eye & ENT Hospital of Fudan University
Shandong Provincial Hospital; Children's Hospital of Fudan University; Xinhua... and other collaborators

Recruiting

IOBT Versus IO-Rec for Hypertropia With IOOA (IIHIOOA)

Hypertropia | Inferior Oblique Overaction

China
Salus University

Terminated

Regimens of Intermittent Occlusion Therapy for Amblyopia in Children

Amblyopia

United States
Universitaire Ziekenhuizen KU Leuven

Active, not recruiting

Foot and Ankle Arthrodesis or Osteotomy With Io-Fix Type Fixation

Foot and Ankle Arthrodesis | Foot and Ankle Osteotomy

Belgium
Haukeland University Hospital
Ministry of Defence, Norway

Completed

Sternal Intraosseous Transfusion of Autologous Whole Blood: A Comparison of Flow Rates and Degree of Hemolysis

Hemorrhagic Shock | Hypovolemic Shock

Norway
Baxano Surgical, Inc.

Unknown

Spondylolisthesis Treated With an iO-Flex® System Enabled Decompression (STRiDE)

Radiculopathy | Lumbar Spinal Stenosis | Spondylolisthesis

United States
HealthPartners Institute
Vidacare Corporation

Completed

Intraosseous Pressure Monitoring in Intensive Care Unit Patients

Blood Pressure

United States
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Peking University

Completed

Study of KN026 Combined With KN046 in Patients With Locally Advanced HER2-positive Solid Tumors

HER2-positive Solid Tumors

China
Salus University
Indiana University

Terminated

Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia

Amblyopia

United States
Vidacare Corporation

Unknown

Infusion Flow Rates and Blood Sampling

Intraosseous Access | Infusion Rates | Intraosseous Blood | Venous Blood

United States
Vidacare Corporation

Terminated

Observational Study of CT Dye Administration Through the Intraosseous Vascular Access Route

Intraosseous Vascular Access Patients Requiring CT Exam

United States
Immune-Onc Therapeutics

Completed

Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors

Solid Tumor, Adult

United States
UNICANCER

Recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients With Metastatic Cancer in Response After 6 Months of Standard IO (MOIO)

Melanoma | Renal Cell Carcinoma | Head and Neck Cancer | Hepatocellular Carcinoma | Lung Cancer Metastatic | Bladder Cancer | Triple Negative Breast Cancer | Merkel Cell Carcinoma

France
University of Roehampton

Recruiting

The Effects of io Fibrewater Supplementation on Gut Health, Immunity and Metabolism in Overweight Adults (IOFW)

Healthy

United Kingdom
Peking University Cancer Hospital & Institute

Recruiting

Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients

Non-small Cell Lung Cancer | Consolidation Immunotherapy | Radiotherapy or Sequential Chemoradiation

China
Guangxi Medical University

Completed

HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC (FRONT-1)

Liver Cancer

China
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Recruiting

A Study to Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer (ANTICIPATE)

Muscle Invasive Bladder Cancer

United States, China
Fudan University

Active, not recruiting

Tislelizumab in the Systematic Treatment of Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Henan Cancer Hospital

Not yet recruiting

Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence

Hepatocellular Carcinoma
Shanghai Gopherwood Biotech Co., Ltd.

Recruiting

Phase I/IIa Study of BR790 in Combination With Tislelizumab in Adult Subjects With Advanced Solid Tumors

Advanced Solid Tumor

China
GeneScience Pharmaceuticals Co., Ltd.

Recruiting

Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors

Malignant Solid Tumors

China
Fudan University

Recruiting

Oncolytic Virotherapy Plus PD-1 Inhibitor for Patients With Refractory Malignant Ascites

Refractory Malignant Ascites

China
Peter MacCallum Cancer Centre, Australia

Recruiting

A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Defects (IMPARP-HRD)

Cancer

Australia
Peking University

Recruiting

Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancer

Gastric Cancer | Colo-rectal Cancer

China
XIANG YANQUN

Recruiting

Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis.

Nasopharyngeal Carcinoma

China
Fudan University

Recruiting

Tislelizumab Plus GX Versus Tislelizumab Plus GP in the Treatment of R/M NPC

Nasopharyngeal Carcinoma

China
Fudan University

Not yet recruiting

Tislelizumab in Combination With Eribulin for Patients With Metastatic Previously heaviLy-treAted TriplE-negative Breast Cancer：A Prospective Multiple-center Phase II Study (TEMPLATE)

Triple Negative Breast Cancer

China

Search clinical trials for: IO-108 tislelizumab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations